Literature DB >> 1876969

Induced hypertension during restoration of flow after temporary middle cerebral artery occlusion in the rat: effect on neuronal injury and edema.

P M Patel1, J C Drummond, D J Cole.   

Abstract

The effect of hypertension instituted during restoration of flow after focal ischemia was studied. After the middle cerebral artery (MCA) of 12 rats was occluded for 2 hours, the ligatures were released and flow was restored for a period of 2 hours. In the control group, mean arterial pressure (MAP) was not manipulated. In the hypertensive group, the MAP was elevated by 25-30 mm Hg immediately after reestablishment of MCA patency. The area of neuronal injury, determined by 2,3,5-triphenyltetrazolium staining, was significantly smaller in the hypertensive group. Specific gravity, determined by microgravimetry, did not differ between groups. The data demonstrate that modest hypertension, when induced during reperfusion after 2 hours of MCA occlusion, reduces neuronal injury and does not exacerbate edema formation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1876969     DOI: 10.1016/0090-3019(91)90112-m

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  3 in total

1.  Mild induced hypertension improves blood flow and oxygen metabolism in transient focal cerebral ischemia.

Authors:  Hwa Kyoung Shin; Masaki Nishimura; Phillip B Jones; Hakan Ay; David A Boas; Michael A Moskowitz; Cenk Ayata
Journal:  Stroke       Date:  2008-03-13       Impact factor: 7.914

2.  Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems.

Authors:  Stefan Braeuninger; Christoph Kleinschnitz
Journal:  Exp Transl Stroke Med       Date:  2009-11-25

Review 3.  Blood Pressure and Penumbral Sustenance in Stroke from Large Vessel Occlusion.

Authors:  Robert W Regenhardt; Alvin S Das; Christopher J Stapleton; Ronil V Chandra; James D Rabinov; Aman B Patel; Joshua A Hirsch; Thabele M Leslie-Mazwi
Journal:  Front Neurol       Date:  2017-07-03       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.